The Future of Treating Autoimmune Diseases: Science, Tech, & Patients Driving Progress
For millions living with autoimmune diseases, progress has long felt out of reach. Approximately 8% of Americans have…
Roche set to take its MS drug to regulators, but safety questions loom
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Injectable Drug Delivery Market in Switzerland | Report – IndexBox
This report is an independent strategic market study that provides a structured, commercially grounded analysis of the market…
Roche Gazyva phase III remission win in kidney disease
Roche (OTCQX:RHHBY) announced that the phase III MAJESTY study in adults with primary…